This project will develop the prism cmevaluate human multiorgan micro-physiological platform to assess radiation-induced injury and evaluate candidate countermeasures under physiologically relevant…
Active Purchase Order Awarded Last action
- Contract number
- 80NSSC26P0952
- Awardee
-
Biopico Systems Inc. UEI MU14LUW1RH41
- Awarding agency
-
Shared Services Center
National Aeronautics and Space Administration
- Obligated
- $249,998
Award facts
- Opportunity
-
- Physiological Radiation Injury using Systemic Multiorgan and Countermeasure Evaluation Solicitation · 80NSSC26936794Q · Posted Jul 1, 2026
- Contract value 100% obligated
- $249,998.10 Current and potential, with all options
- Completion date 62% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- PSC
- AJ11 General Science And Technology R&D Services; General Science And Technology; Basic Research
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Irvine, CA 92618, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $249,998 |
About this award
NASA's Shared Services Center issued a purchase order to Biopico Systems Inc. on July 7, 2026, valued at $249,998.10, for development of the PRISM (Platform for Radiation-Induced Senescence using Multiorgans) human microphysiological platform to assess radiation-induced injury and evaluate candidate countermeasures. This was a sole-source procurement under FAR 12.102(a). Work is performed in Irvine, California, with administrative oversight at NASA Johnson Space Center, Houston, Texas. The contractor will establish an integrated system combining cerebral organoids, cardiac organoids, liver tissues, and endothelial barriers under recirculating flow conditions, exposing tissues to radiation at 0.5, 1, and 2 Gy levels and evaluating four candidate countermeasure compounds—NAC, Metformin, Fisetin, and Amifostine—using reactive oxygen species markers, DNA damage markers, cytokine analysis, and tissue-specific functional assays. Deliverables include radiation dose-response datasets, quantitative biomarker analysis, countermeasure evaluation results, and a final analyzed dataset with summary report formatted to NASA data submission requirements. Performance period runs through January 6, 2027.
Description
This project will develop the prism cmevaluate human multiorgan micro-physiological platform to assess radiation-induced injury and evaluate candidate countermeasures under physiologically relevant recirculating flow conditions
Quick answers
Who was awarded contract 80NSSC26P0952?
80NSSC26P0952 was awarded to Biopico Systems Inc. by Shared Services Center (National Aeronautics and Space Administration) on July 7, 2026.
How much is contract 80NSSC26P0952 worth?
The government has obligated $249,998 on 80NSSC26P0952.
Was contract 80NSSC26P0952 competed?
The extent of competition for 80NSSC26P0952 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award